Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating chronic obstructive pulmonary disease at stable stage and preparation method and application thereof

A technology for chronic obstructive pulmonary disease and composition, which can be used in drug combinations, pharmaceutical formulations, respiratory system diseases, etc., can solve problems such as the stable period of chronic obstructive pulmonary disease, and achieve no toxic side effects, good safety, and ease of use. effect of clinical symptoms

Active Publication Date: 2019-05-21
TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are no sunburned astragalus, schisandra, inula inula, codonopsis, fried Atractylodes macrocephala, dried ginger, French pinellia tangerine peel, rehmannia glutinosa, dogwood, cinnamon, angelica, bellflower, Poria cocos, asarum, and licorice for the treatment of chronic obstructive pulmonary disease. Reports of stable lung disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating chronic obstructive pulmonary disease at stable stage and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1, the preparation of pharmaceutical composition of the present invention

[0025] Prescription: Radix Astragali 20g, Schisandra 10g, Inula 15g, Codonopsis 15g, Atractylodes 15g, Dried Ginger 10g, Pinellia 15g, Chenpi 15g, Rehmannia glutinosa 20g, Cornus officinalis 15g, Cinnamon 10g, Angelica 15g, Campanulaceae 10g, Poria cocos 15g, asarum 3g, roasted licorice 5g.

[0026] Preparation method: according to the above prescription ratio, first mix honey Inula flower (packaged separately), roasted astragalus, Schisandra chinensis, Codonopsis pilosula, fried Atractylodes macrocephala, dried ginger, French pinellia, tangerine peel, rehmannia glutinosa, dogwood, cinnamon, angelica, bellflower, Put Poria cocos, asarum, and roasted licorice into a casserole, add 3000ml of water, and soak for 0.5 hours. Boil for 20 minutes with strong fire (high fire), and cook with slow fire (low fire) until 150-200ml is left, and pour the boiled medicinal liquid into a clean contai...

Embodiment 2

[0027] Embodiment 2, the preparation of pharmaceutical composition of the present invention

[0028] Prescription: Radix Astragalus 10g, Schisandra 5g, Inula 10g, Codonopsis 10g, Stir-fried Atractylodes 10g, Dried Ginger 5g, Pinellia 10g, Chenpi 10g, Rehmannia glutinosa 10g, Cornus officinalis 10g, Cinnamon 5g, Angelica 10g, Campanulaceae 5g, Poria cocos 10g, asarum 1g, roasted licorice 3g.

[0029] Preparation method: with embodiment 1.

Embodiment 3

[0030] Embodiment 3, the preparation of pharmaceutical composition of the present invention

[0031] Prescription: Radix Astragali 30g, Schisandra 15g, Inula 20g, Codonopsis 20g, Atractylodes 20g, Dried Ginger 15g, Pinellia 20g, Chenpi 20g, Rehmannia glutinosa 30g, Cornus officinalis 20g, Cinnamon 15g, Angelica 20g, Campanulaceae 15g, Poria cocos 20g, asarum 4g, roasted licorice 6g.

[0032] Preparation method: with embodiment 1.

[0033] The beneficial effects of the present invention are illustrated below through test examples.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for treating a chronic obstructive pulmonary disease at a stable stage. The pharmaceutical composition is a preparation prepared from, by weight, the following raw materials: 10-30 parts of radix astragali preparata, 5-15 parts of schisandra chinensis, 10-20 parts of honey processed inula flowers, 10-20 parts of codonopsis pilosula, 10-20 parts of stir-fried bighead atractylodes rhizome, 5-15 parts of dried ginger, 10-20 parts of pinellia ternata, 10-20 parts of dried tangerine peel, 10-30 parts of prepared rehmannia root, 10-20 parts of dogwood, 5-15 parts of cinnamon and 10-20 parts of angelica sinensis, 5-15 parts of platycodon grandiflorum, 10-20 parts of poria cocos, 1-4 parts of asarum and 3-6 parts of honey-fried licorice roots. The pharmaceutical composition is exquisite in formula, can remarkably relieve clinical symptoms of patients suffering from the chronic obstructive pulmonary disease at the stable stage and effectivelytreat the chronic obstructive pulmonary disease at the stable stage. In addition, the composition is good in safety, free of toxic and side effects and convenient to use, and provides a new drug selection for clinically treating the chronic obstructive pulmonary disease at the stable stage.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a pharmaceutical composition for treating stable chronic obstructive pulmonary disease, a preparation method and application thereof. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a preventable and preventable disease characterized by persistent airflow limitation, which usually develops progressively and is harmful to the airway and lung tissue, such as cigarette smoke. Associated with an abnormal chronic inflammatory response to gases or noxious particles. Stable chronic obstructive pulmonary disease refers to patients with chronic obstructive pulmonary disease who have stable or mild symptoms such as cough, expectoration, and shortness of breath, and their condition has basically returned to the state before the acute exacerbation. Chronic obstructive pulmonary disease is a common and frequently-occurring disease, and the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P11/00
Inventor 黄青松张传涛吴建英肖玮王成黄群
Owner TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products